Loading…
Loading…
EQUITY / NASDAQ · XNCM
NervGen Pharma Corp.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →01/01/2025 – 12/31/2025 · CAD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗1.78 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 1.78 USD · Volume 409,606
185 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
01/01/2025 – 12/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Net income | -44,117,305 CAD | -24,250,049 CAD | — |
| Operating cash flow | -19,499,211 CAD | -16,841,034 CAD | — |
| Cash and cash equivalents | 22,069,635 CAD | 17,267,489 CAD | +27.81% |
| Total liabilities | 19,732,715 CAD | 16,909,616 CAD | +16.70% |
| Total equity | 3,476,926 CAD | 2,576,607 CAD | +34.94% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · CAD | 2024 / Year end01/01/2024 – 12/31/2024ConsolidatedUnits · CAD | 2023 / Year end12/31/2023 – 12/31/2023ConsolidatedUnits · CAD |
|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 22,069,635 CAD | 17,267,489 CAD | 11,659,544 CAD |
| Financing cash flowCash flow statement | 23,763,937 CAD | 22,695,111 CAD | — |
| Investing cash flowCash flow statement | 100,926 CAD | 58,874 CAD | — |
| Net incomeIncome statement | -44,117,305 CAD | -24,250,049 CAD | — |
| Operating cash flowCash flow statement | -19,499,211 CAD | -16,841,034 CAD | — |
| Total assetsBalance sheet | 23,209,641 CAD | 19,486,223 CAD | — |
| Total equityBalance sheet | 3,476,926 CAD | 2,576,607 CAD | -2,009,105 CAD |
| Total liabilitiesBalance sheet | 19,732,715 CAD | 16,909,616 CAD | — |
| Report source | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 03/31/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.